Biogen Idec Inc. | Key People and Executives
Michel Vounatsos
Chief Executive Officer & Director
Stelios B. Papadopoulos
Chairman
Eric K. Rowinsky
Independent Director
Stephen A. Sherwin
Independent Director
Lynn Schenk
Independent Director
Caroline D. Dorsa
Independent Director
Richard Mulligan
Independent Director
Alex J. Denner
Independent Director
Brian S. Posner
Independent Director
Robert W. Pangia
Independent Director
Nancy L. Leaming
Independent Director
Michel Vounatsos
Chief Executive Officer & Director
Jeffrey D. Capello
Chief Financial Officer & Executive Vice President
Michael D. Ehlers
Executive VP-Research & Development
Alfred W. Sandrock
Chief Medical Officer & Executive Vice President
Mark Hernon
Chief Information Officer & Senior Vice President
Daniel Karp
Executive Vice President-Corporate Development
Alisha A. Alaimo
Senior Vice President-US Therapeutic Operations
Sanjay Jariwala
Senior Vice President-Worldwide Medical
Anirvan Ghosh
Senior Vice President-Research & Early Development
Camille Lee
Senior VP-Alzheimer Therapeutic Area
Anabella Villalobos
SVP-Biotherapeutic & Medicinal Sciences
Paul McKenzie
EVP-Pharmaceutical Operations & Technology
Jesse M. Cedarbaum
VP-Clinical Development
Samantha Budd Haeberlein
Vice President-Discovery & Development
Simon Nicholas Tate
Vice President & Head-Pain Therapeutic Area
Wildon R. Farwell
Senior Medical Director
Jake Elkins
Senior Medical Director
Christopher Henderson
Vice President-Neurology Division
Ed Dondero
Director-Real Estate & Planning
John McDonald
Head-Business Development, Mergers & Acquisition
Richard A. Rudick
Vice President-Development Sciences
Chirfi Guindo
Executive Vice President & Head-Global Marketing
Gregory F. Covino
Chief Accounting Officer & Vice President-Finance
David Caouette
Head-Media Relations
Matthew Calistri
Senior Director-Investor Relations
Ginger Gregory
Chief Human Resources Officer & Executive VP
Susan H. Alexander
Secretary, Chief Legal Officer & Executive VP
Amy Chevalier Efantis
Vice President-Government Affairs
Stelios B. Papadopoulos
Chairman
Eric K. Rowinsky
Independent Director
Stephen A. Sherwin
Independent Director
Lynn Schenk
Independent Director
Caroline D. Dorsa
Independent Director
Richard Charles Mulligan
Independent Director
Alexander John Denner
Independent Director
Brian S. Posner
Independent Director
Robert W. Pangia
Independent Director
Nancy L. Leaming
Independent Director
| Address |
225 Binney Street
Cambridge Massachusetts 02142
United States
|
|
Employees
|
- |
| Website |
http://www.biogen.com |
| Updated |
07/08/2019 |
| Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA. |
